These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15144934)

  • 41. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 42. Tolerability of carvedilol in heart failure: clinical trials experience.
    Krum H
    Am J Cardiol; 2004 May; 93(9A):58B-63B. PubMed ID: 15144940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Now there are four: Carvedilol takes its place in therapeutical line-up for heart failure.
    Phillips L
    Hosp Technol Ser; 1997 Mar; 16(3):6-7. PubMed ID: 10166705
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program.
    Vera-Llonch M; Menzin J; Richner RE; Oster G
    Ann Pharmacother; 2001; 35(7-8):846-51. PubMed ID: 11485131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carvedilol.
    Can Fam Physician; 1999 May; 45():1199-202, 1205-9. PubMed ID: 10349064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb; 145(8):57. PubMed ID: 12661451
    [No Abstract]   [Full Text] [Related]  

  • 48. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 49. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
    J Am Coll Cardiol; 1997 Apr; 29(5):1060-6. PubMed ID: 9120160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial.
    Tillmann HC; Sharpe N; Sponer G; Wehling M
    Int J Clin Pharmacol Ther; 2001 May; 39(5):205-12. PubMed ID: 11380066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?
    Wollert KC; Drexler H
    Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of carvedilol on mortality and morbidity in patients with chronic heart failure.
    Circulation; 1996 Aug; 94(4):592. PubMed ID: 8772669
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of beta blockers on symptoms and functional capacity in heart failure.
    Fowler MB
    Am J Cardiol; 1997 Dec; 80(11A):55L-58L. PubMed ID: 9412543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Carvedilol and heart failure: new findings].
    Cosín Aguilar J
    Rev Esp Cardiol; 1996 Feb; 49(2):85-7. PubMed ID: 8948716
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
    Buchwald A; Unterberg C; van der Does R; Wiegand V
    Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
    Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
    Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Beta blockers in heart failure].
    Heinzl S
    Med Monatsschr Pharm; 1996 Feb; 19(2):37. PubMed ID: 8852061
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.
    Lowes BD; Gill EA; Abraham WT; Larrain JR; Robertson AD; Bristow MR; Gilbert EM
    Am J Cardiol; 1999 Apr; 83(8):1201-5. PubMed ID: 10215284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary results of COPERNICUS, a pivotal landmark study (Carvedilol Prospective Randomised Cumulative Survival Trial).
    Cardiovasc J S Afr; 2001; 12(1):57. PubMed ID: 11474691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.